The FDA Is Out Of Control
November 4th, 2007 | Posted by CTLCareToLive, a not for profit corporation, is a group which advocates for men with terminal stage prostate cancer. These men are desperately seeking access to Provenge, a proven safe and effective immunotherapy, to help them in their fight for their lives. One in six men will come down with prostate cancer. Only one very toxic treatment, a chemotherapy, has been approved for late stage prostate cancer in over 42 years.
Provenge is an immunotherapy which retrains one’s healthy cells to fight off the cancer cells, unlike radiation and chemotherapy which indiscriminately kills off one’s healthy cells along with one’s cancerous cells. Provenge has proven to be safe and effective and was overwhelmingly voted for by an FDA Advisory Committee, yet the FDA delayed approval indefinitely.
Cancer, Chemotherapy and the Side Effect Management through drugs is big business. It is time for the chemo cartel to let go. We want access to the immunotherapy Provenge now. We have filed a lawsuit in Federal Court against the FDA. Please Help Us Help Men Gain Access to Provenge NOW! PLEASE JOIN US!
Popularity: 67%
Tags: Andrew Von Eschenbach, Care To Live, CareToLive, Dendreon, Dr. Mark Moyad, FDA, Health and Human Services, Mike Leavitt, Prostate Cancer, provenge, Richard Pazdur
November 23rd, 2007 at 6:37 am
i am 59 years old in the last months of my life this is my only hope how could they do this to anybody